US IND (investigational new drug) launch for Gen-Probe/Chiron WNV (West Nile virus) blood screen
This article was originally published in Clinica
Executive Summary
Gen-Probe says that "within weeks", about 80% of the US donated blood supply will be screened using its West Nile virus (WNV) assay, which is approved for non-commercial use under an investigational new drug (IND) licence.